128 related articles for article (PubMed ID: 1373760)
1. Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.
Redman JR; Cabanillas F; Velasquez WS; McLaughlin P; Hagemeister FB; Swan F; Rodriguez MA; Plunkett WK; Keating MJ
J Clin Oncol; 1992 May; 10(5):790-4. PubMed ID: 1373760
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.
Solal-Céligny P; Brice P; Brousse N; Caspard H; Bastion Y; Haïoun C; Bosly A; Tilly H; Bordessoule D; Sebban C; Harousseau JL; Morel P; Dupas B; Plassart F; Vasile N; Fort N; Leporrier M
J Clin Oncol; 1996 Feb; 14(2):514-9. PubMed ID: 8636765
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomas.
Decaudin D; Bosq J; Tertian G; Nedellec G; Bennaceur A; Venuat AM; Bayle C; Carde P; Bendahmane B; Hayat M; Munck JN
J Clin Oncol; 1998 Feb; 16(2):579-83. PubMed ID: 9469344
[TBL] [Abstract][Full Text] [Related]
4. Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
Foran JM; Rohatiner AZ; Coiffier B; Barbui T; Johnson SA; Hiddemann W; Radford JA; Norton AJ; Tollerfield SM; Wilson MP; Lister TA
J Clin Oncol; 1999 Feb; 17(2):546-53. PubMed ID: 10080598
[TBL] [Abstract][Full Text] [Related]
5. Fludarabine phosphate therapy of non-Hodgkin's lymphoma.
Hochster H; Cassileth P
Semin Oncol; 1990 Oct; 17(5 Suppl 8):63-5. PubMed ID: 1699284
[TBL] [Abstract][Full Text] [Related]
6. Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma.
Hagenbeek A; Eghbali H; Monfardini S; Vitolo U; Hoskin PJ; de Wolf-Peeters C; MacLennan K; Staab-Renner E; Kalmus J; Schott A; Teodorovic I; Negrouk A; van Glabbeke M; Marcus R
J Clin Oncol; 2006 Apr; 24(10):1590-6. PubMed ID: 16575010
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive phase I and II clinical investigation of fludarabine phosphate.
Grever M; Leiby J; Kraut E; Metz E; Neidhart J; Balcerzak S; Malspeis L
Semin Oncol; 1990 Oct; 17(5 Suppl 8):39-48. PubMed ID: 1699282
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma.
Tobinai K; Watanabe T; Ogura M; Morishima Y; Ogawa Y; Ishizawa K; Minami H; Utsunomiya A; Taniwaki M; Terauchi T; Nawano S; Matsusako M; Matsuno Y; Nakamura S; Mori S; Ohashi Y; Hayashi M; Seriu T; Hotta T
J Clin Oncol; 2006 Jan; 24(1):174-80. PubMed ID: 16330664
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma.
Morris GJ; Millenson MM; Padavic-Shaller K; Wang H; Rogatko A; Clyde J; Boyd RL; Yeslow G; Halbherr T; Schilder RJ; Smith MR
Haematologica; 2004 Dec; 89(12):1484-91. PubMed ID: 15590399
[TBL] [Abstract][Full Text] [Related]
10. Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.
Hochster HS; Kim KM; Green MD; Mann RB; Neiman RS; Oken MM; Cassileth PA; Stott P; Ritch P; O'Connell MJ
J Clin Oncol; 1992 Jan; 10(1):28-32. PubMed ID: 1727921
[TBL] [Abstract][Full Text] [Related]
11. Phase I clinical trials with fludarabine phosphate.
Von Hoff DD
Semin Oncol; 1990 Oct; 17(5 Suppl 8):33-8. PubMed ID: 1699281
[TBL] [Abstract][Full Text] [Related]
12. [The use of fludarabine phosphate (Fludara) to treat chronic B-cell lymphocytic leukemia and non-Hodgkin's lymphoma resistant to standard chemotherapy].
Gershanovich ML; Zaritskiĭ AIu; Medvedeva NV; Abdulkadyrov KM; Samuskevich IG; Beresneva IA
Vopr Onkol; 1998; 44(6):696-700. PubMed ID: 10087967
[TBL] [Abstract][Full Text] [Related]
13. New initiatives with fludarabine monophosphate in hematologic malignancies.
Keating MJ; O'Brien S; Robertson LE; Kantarjian H; Dimopoulos M; McLaughlin P; Cabanillas F; Gregoire V; Yang LY; Gandhi V
Semin Oncol; 1993 Oct; 20(5 Suppl 7):13-20. PubMed ID: 7694371
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomas.
Fenchel K; Bergmann L; Wijermans P; Engert A; Pralle H; Mitrou PS; Diehl V; Hoelzer D
Leuk Lymphoma; 1995 Aug; 18(5-6):485-92. PubMed ID: 8528057
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia.
Foran JM; Oscier D; Orchard J; Johnson SA; Tighe M; Cullen MH; de Takats PG; Kraus C; Klein M; Lister TA
J Clin Oncol; 1999 May; 17(5):1574-9. PubMed ID: 10334546
[TBL] [Abstract][Full Text] [Related]
16. Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report.
Sorensen JM; Vena DA; Fallavollita A; Chun HG; Cheson BD
J Clin Oncol; 1997 Feb; 15(2):458-65. PubMed ID: 9053466
[TBL] [Abstract][Full Text] [Related]
17. Phase I and pharmacokinetic study of oral fludarabine phosphate in relapsed indolent B-cell non-Hodgkin's lymphoma.
Ogawa Y; Hotta T; Tobinai K; Watanabe T; Sasaki Y; Minami H; Morishima Y; Ogura M; Seriu T
Ann Oncol; 2006 Feb; 17(2):330-3. PubMed ID: 16275653
[TBL] [Abstract][Full Text] [Related]
18. Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.
Rodriguez G
Invest New Drugs; 1994; 12(2):75-92. PubMed ID: 7532163
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.
Chun HG; Leyland-Jones B; Cheson BD
J Clin Oncol; 1991 Jan; 9(1):175-88. PubMed ID: 1702143
[TBL] [Abstract][Full Text] [Related]
20. [Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia].
Miyawaki S; Imamura M; Kobayashi S; Ohnishi K; Hodohara K; Mizoguchi H; Tomonaga M; Tango T; Ohno R
Rinsho Ketsueki; 1999 Dec; 40(12):1236-44. PubMed ID: 10658476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
